Adonay S Nunes, İlkay Yıldız Potter, Ram Kinker Mishra, Jose Casado, Nima Dana, Andrew Geronimo, Christopher G Tarolli, Ruth B Schneider, E Ray Dorsey, Jamie L Adams, Ashkan Vaziri
{"title":"Using wearable sensors and machine learning to assess upper limb function in Huntington's disease.","authors":"Adonay S Nunes, İlkay Yıldız Potter, Ram Kinker Mishra, Jose Casado, Nima Dana, Andrew Geronimo, Christopher G Tarolli, Ruth B Schneider, E Ray Dorsey, Jamie L Adams, Ashkan Vaziri","doi":"10.1038/s43856-025-00770-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Huntington's disease, a neurodegenerative disorder, impairs both upper and lower limb function, typically assessed in clinical settings. However, wearable sensors offer the opportunity to monitor real-world data that complements clinical assessments, providing a more comprehensive understanding of disease symptoms.</p><p><strong>Methods: </strong>In this study, we monitor upper limb function in individuals with Huntington's disease (HD, n = 16), prodromal HD (pHD, n = 7), and controls (CTR, n = 16) using a wrist-worn wearable sensor over a 7-day period. Goal-directed hand movements are detected through a deep learning model, and kinematic features of each movement are analyzed. The collected data is used to predict disease groups and clinical scores using statistical and machine learning models.</p><p><strong>Results: </strong>Here we show that significant differences in goal-directed movement features exist between the groups. Additionally, several of these features strongly correlate with clinical scores. Classification models accurately distinguish between HD, pHD, and CTR individuals, achieving a balanced accuracy of 67% and a recall of 0.72 for the HD group. Regression models effectively predict clinical scores.</p><p><strong>Conclusions: </strong>This study demonstrates the potential of wearable sensors and machine learning to monitor upper limb function in Huntington's disease, offering a tool for early detection, remote monitoring, and assessing treatment efficacy in clinical trials.</p>","PeriodicalId":72646,"journal":{"name":"Communications medicine","volume":"5 1","pages":"50"},"PeriodicalIF":5.4000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11861259/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communications medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s43856-025-00770-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Huntington's disease, a neurodegenerative disorder, impairs both upper and lower limb function, typically assessed in clinical settings. However, wearable sensors offer the opportunity to monitor real-world data that complements clinical assessments, providing a more comprehensive understanding of disease symptoms.
Methods: In this study, we monitor upper limb function in individuals with Huntington's disease (HD, n = 16), prodromal HD (pHD, n = 7), and controls (CTR, n = 16) using a wrist-worn wearable sensor over a 7-day period. Goal-directed hand movements are detected through a deep learning model, and kinematic features of each movement are analyzed. The collected data is used to predict disease groups and clinical scores using statistical and machine learning models.
Results: Here we show that significant differences in goal-directed movement features exist between the groups. Additionally, several of these features strongly correlate with clinical scores. Classification models accurately distinguish between HD, pHD, and CTR individuals, achieving a balanced accuracy of 67% and a recall of 0.72 for the HD group. Regression models effectively predict clinical scores.
Conclusions: This study demonstrates the potential of wearable sensors and machine learning to monitor upper limb function in Huntington's disease, offering a tool for early detection, remote monitoring, and assessing treatment efficacy in clinical trials.